<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="editorial">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">kqdQ3z4kR3PGHkDB9Zj8TgL</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2013000400017</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(13)10000400017</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20130085</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Ponto de Vista</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Medida do consumo m&#225;ximo de oxig&#234;nio: valioso marcador biol&#243;gico na sa&#250;de e na doen&#231;a</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ara&#250;jo</surname>
            <given-names>Claudio Gil Soares de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Herdy</surname>
            <given-names>Artur Haddad</given-names>
          </name>
          <xref ref-type="aff" rid="aff03"/>
          <xref ref-type="aff" rid="aff04"/>
          <xref ref-type="aff" rid="aff05"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stein</surname>
            <given-names>Ricardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff06"/>
          <xref ref-type="aff" rid="aff07"/>
        </contrib>
      </contrib-group>
      <aff id="aff06">
        <addr-line>
          <named-content content-type="city">Porto Alegre</named-content>
          <named-content content-type="state">Rio Grande do Sul</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal do Rio Grande do Sul</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">Departamento de Medicina Interna</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff05">
        <addr-line>
          <named-content content-type="city">Florian&#243;polis</named-content>
          <named-content content-type="state">Santa Catarina</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade do Sul de Santa Catarina</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">Cl&#237;nica de Medicina do Exerc&#237;cio</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Gama Filho</institution>
        <institution content-type="orgdiv1">Programa de P&#243;s-Gradua&#231;&#227;o em Ci&#234;ncias do Exerc&#237;cio e do Esporte </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff04">
        <addr-line>
          <named-content content-type="state">Santa Catarina</named-content>
        </addr-line>
        <institution content-type="orgname">Cl&#237;nica Cardiosport</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="state">Santa Catarina</named-content>
        </addr-line>
        <institution content-type="orgname">Instituto de Cardiologia de Santa Catarina</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff07">
        <addr-line>
          <named-content content-type="city">Porto Alegre</named-content>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">Vitta Exerc&#237;cio &amp; Cl&#237;nica de Sa&#250;de</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>04</month>
        <year>2013</year>
      </pub-date>
      <volume>100</volume>
      <issue>4</issue>
      <fpage>e51</fpage>
      <lpage>e53</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <pub-date publication-format="electronic" date-type="pub">
        <day>06</day>
        <month>05</month>
        <year>2013</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>PONTO DE VISTA</bold>
    </p>
    <p>
      <bold>Medida do consumo m&#225;ximo de oxig&#234;nio: valioso marcador biol&#243;gico na sa&#250;de e na doen&#231;a</bold>
    </p>
    <p>
      <bold>Claudio Gil Soares de Ara&#250;jo<sup>I,II</sup>; Artur Haddad Herdy<sup>III,IV,V</sup>; Ricardo Stein<sup>VI,VII</sup></bold>
    </p>
    <p><sup>I</sup>Programa de P&#243;s-Gradua&#231;&#227;o em Ci&#234;ncias do Exerc&#237;cio e do Esporte - Universidade Gama Filho </p>
    <p><sup>II</sup>Cl&#237;nica de Medicina do Exerc&#237;cio (Clinimex), Rio de Janeiro, RJ </p>
    <p><sup>III</sup>Instituto de Cardiologia de Santa Catarina </p>
    <p><sup>IV</sup>Cl&#237;nica Cardiosport </p>
    <p><sup>V</sup>Universidade do Sul de Santa Catarina (Unisul), Florian&#243;polis, SC </p>
    <p><sup>VI</sup>Departamento de Medicina Interna da Faculdade de Medicina - Universidade Federal do Rio Grande do Sul, Porto Alegre, RS </p>
    <p><sup>VII</sup>Vitta Exerc&#237;cio &amp; Cl&#237;nica de Sa&#250;de, Porto Alegre, RS - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p><bold>Palavras-chave:</bold> Teste cardiopulmonar de exerc&#237;cio; Ergoespirometria; Ergometria; Condi&#231;&#227;o aer&#243;bica; Aptid&#227;o f&#237;sica; Avalia&#231;&#227;o funcional.</p>
    <p>O ser humano depende do oxig&#234;nio (O<sub>2</sub>) atmosf&#233;rico para sua sobreviv&#234;ncia. Para a realiza&#231;&#227;o de um trabalho f&#237;sico h&#225; a necessidade de aumentar a entrada de ar para os pulm&#245;es, incrementar a circula&#231;&#227;o sangu&#237;nea e ativar vias metab&#243;licas espec&#237;ficas nos m&#250;sculos esquel&#233;ticos, resultando em uma maior capta&#231;&#227;o e utiliza&#231;&#227;o do O<sub>2</sub>. Respostas integradas dos sistemas respirat&#243;rio, cardiovascular e muscular em exerc&#237;cios que envolvam grandes grupos musculares aumentam at&#233; um limite que define o consumo m&#225;ximo de oxig&#234;nio (VO<sub>2</sub>m&#225;x) ou condi&#231;&#227;o aer&#243;bica do indiv&#237;duo. Considerando que o corpo humano &#233; uma m&#225;quina capaz de transformar energia qu&#237;mica em trabalho mec&#226;nico, ao VO<sub>2</sub>m&#225;x corresponde um desempenho f&#237;sico, que &#233; definido como Capacidade Funcional M&#225;xima (CFM) e pode ser estimado com bastante acur&#225;cia. Excetuando os casos extremos de maior ou menor efici&#234;ncia mec&#226;nica, como atletas muito t&#233;cnicos no gesto motor ou deficientes f&#237;sicos com grande redu&#231;&#227;o de funcionalidade, para praticamente todos os demais indiv&#237;duos, h&#225;, em geral, uma associa&#231;&#227;o significativa entre VO<sub>2</sub>m&#225;x e CFM<sup>1</sup>. Esse ponto de vista aborda, sucintamente, os principais aspectos hist&#243;ricos e metodol&#243;gicos e os significados fisiol&#243;gico, epidemiol&#243;gico e cl&#237;nico do VO<sub>2</sub>m&#225;x, al&#233;m de apontar o seu papel relevante como marcador de sa&#250;de e de desempenho f&#237;sico.</p>
    <p>Quando em situa&#231;&#245;es de exerc&#237;cio, mecanismos fisiol&#243;gicos podem aumentar a ventila&#231;&#227;o alveolar de 10 a 30 vezes; a frequ&#234;ncia card&#237;aca de 3 a 4 vezes; o d&#233;bito card&#237;aco em 5 a 6 vezes; e a extra&#231;&#227;o perif&#233;rica arteriovenosa de O<sub>2</sub> em algumas vezes. Dessa forma, o VO<sub>2</sub> aumenta na propor&#231;&#227;o direta da intensidade do esfor&#231;o. Enquanto o VO<sub>2</sub>m&#225;x tende a ser maior em homens e a diminuir com o envelhecimento, &#233; na medida do VO<sub>2</sub>m&#225;x que os seres humanos acabam por se diferenciar. Em condi&#231;&#245;es de repouso, um adulto tende a consumir pouco mais de 200 mL de O<sub>2</sub> (aproximadamente 1 kcal) por minuto ou algo como 3,5 mL O<sub>2</sub>.kg<sup>-1</sup>.min<sup>-1</sup>. Para simplificar, convencionou-se denominar essa magnitude de gasto energ&#233;tico em repouso como 1 equivalente metab&#243;lico (MET). Enquanto alguns cardiopatas, pneumopatas e indiv&#237;duos muito idosos podem ser limitados a apenas 3 ou 4 METs ou VO<sub>2</sub>m&#225;x entre 10 e 14 mL O<sub>2</sub>.kg<sup>-1</sup>.min<sup>-1</sup>, homens de meia-idade ativos costumam ter um VO<sub>2</sub>m&#225;x variando entre 25 e 35 mL O<sub>2</sub>.kg<sup>-1</sup>. min<sup>-1</sup>, adolescentes e adultos jovens entre 35 e 55, e atletas de elite em modalidades predominantemente aer&#243;bicas podem at&#233; ultrapassar 70 mL O<sub>2</sub>.kg<sup>-1</sup>.min<sup>-1</sup><sup>2</sup>. Muito embora em um esfor&#231;o abrupto e de alt&#237;ssima intensidade um indiv&#237;duo jovem e saud&#225;vel possa alcan&#231;ar o VO<sub>2</sub>m&#225;x em pouco mais de um minuto, como de fato ocorre em diversas provas desportivas, na pr&#225;tica cl&#237;nica s&#227;o utilizados protocolos de teste de exerc&#237;cio com pequenos incrementos ou em rampa lenta, objetivando alcan&#231;ar um VO<sub>2</sub>m&#225;x ao redor de dez minutos de dura&#231;&#227;o e favorecendo a interpreta&#231;&#227;o das diversas vari&#225;veis cardiorrespirat&#243;rias e eletrocardiogr&#225;ficas.</p>
    <p>Historicamente, sabe-se que os primeiros estudos com medidas de VO<sub>2</sub>m&#225;x foram publicados h&#225; mais de uma centena de anos, inclusive contribuindo para que o fisiologista Archibald V. Hill, um dos indiv&#237;duos testados e autor desses estudos, viesse a ser laureado com o Pr&#234;mio Nobel de Fisiologia e Medicina em 1922<sup>2</sup>. No Brasil, essa medida come&#231;ou a ser feita primariamente em laborat&#243;rios de fisiologia do exerc&#237;cio no in&#237;cio dos anos 1970. Em um passado n&#227;o t&#227;o distante, a avalia&#231;&#227;o do VO<sub>2</sub>m&#225;x era restrita a alguns centros especializados. No entanto, na atualidade, cresce muito rapidamente o n&#250;mero de locais capazes de efetivamente medir o VO<sub>2</sub>m&#225;x durante um teste cardiopulmonar de exerc&#237;cio m&#225;ximo (TCPE). Por exemplo, combinando os autores desse ponto de vista, j&#225; s&#227;o mais de 20 mil procedimentos nos &#250;ltimos 40 anos.</p>
    <p>O VO<sub>2</sub>m&#225;x pode ser medido de forma direta atrav&#233;s da an&#225;lise dos gases expirados durante um TCPE ou estimado atrav&#233;s de equa&#231;&#245;es baseadas em dist&#226;ncia percorridas em um certo tempo - por exemplo, o teste de Cooper - ou na dura&#231;&#227;o de um teste de exerc&#237;cio com determinado protocolo (Bruce ou Ellestad, por exemplo). Mesmo que em algumas circunst&#226;ncias a aplica&#231;&#227;o dessas equa&#231;&#245;es de predi&#231;&#227;o possa resultar em boa associa&#231;&#227;o com os valores obtidos nas medidas diretas, o erro para um dado indiv&#237;duo pode ser bastante alto, girando em torno de 15% a 20% e, em raros casos, alcan&#231;ar ou exceder 30%, uma margem que n&#227;o &#233; encontrada em outras medidas da &#225;rea biol&#243;gica. Desse modo, sempre que poss&#237;vel e consoante com uma tend&#234;ncia atual, &#233; prefer&#237;vel realizar um TCPE verdadeiramente m&#225;ximo<sup>3</sup> e obter medidas diretas e mais precisas do VO<sub>2</sub>m&#225;x.</p>
    <p>Em situa&#231;&#245;es nas quais se observa uma limita&#231;&#227;o no VO<sub>2</sub>m&#225;x ou quando s&#227;o alcan&#231;ados valores muito abaixo dos previstos para a idade e sexo, um significado diagn&#243;stico pode advir, especialmente, quando tais resultados passam a ser comparados com testes pr&#233;vios que apresentaram resultado dentro da normalidade. No entanto, a maior relev&#226;ncia da determina&#231;&#227;o do VO<sub>2</sub>m&#225;x e da CFM est&#225; na sua utiliza&#231;&#227;o progn&#243;stica. Estudos cl&#225;ssicos com grandes amostras de indiv&#237;duos de meia-idade e idosos de diferentes partes do mundo t&#234;m repetidamente encontrado que o risco de mortalidade por todas as causas em seguimentos entre 5 e 20 anos pode variar de uma a cinco vezes para os indiv&#237;duos dispostos nos quartis ou quintis mais extremos de VO<sub>2</sub>m&#225;x ou CFM<sup>4-6</sup>. Para homens adultos de meia-idade, o incremento de 3,5 mL O<sub>2</sub>.kg<sup>-1</sup>.min<sup>-1 </sup>corresponde a um ganho de 12% na expectativa de vida<sup>6</sup>. Colocando essa informa&#231;&#227;o na devida perspectiva cl&#237;nica de estratifica&#231;&#227;o de risco individual, pode-se comparar a taxa de mortalidade anual de homens de meia-idade em diferentes condi&#231;&#245;es cl&#237;nicas e de VO<sub>2</sub>m&#225;x (<xref ref-type="table" rid="a17tab01">Tabela 1</xref>). Com base nesses dados epidemiol&#243;gicos, fica claro que possuir um VO<sub>2</sub>m&#225;x (ou CFM) proporcionalmente alto &#233; um forte sinal de sa&#250;de e longevidade. Homens que aos 50 anos de idade completam uma corrida de 10 km com tempo inferior a 50 minutos apresentar&#227;o um excelente progn&#243;stico no que tange &#224; expectativa de vida nos 5 a 10 anos seguintes<sup>7</sup>. Por outro lado, "saud&#225;veis" (com avalia&#231;&#227;o cardiol&#243;gica normal) com VO<sub>2</sub>m&#225;x inferior a 17 mL O<sub>2</sub>.kg<sup>-1</sup>.min<sup>-1</sup> (cerca de 50%-60% do previsto para a idade e g&#234;nero), apresentam uma taxa de mortalidade anual de aproximadamente 5%<sup>6</sup>, n&#227;o muito distinta daquela observada ap&#243;s o diagn&#243;stico de um c&#226;ncer de intestino, que, de acordo com os dados mais recentes do CDC norte-americano, giram em torno de 7%/ano<sup>13</sup>.</p>
    <p content-type="asset">
      <table-wrap id="a17tab01">
        <graphic xlink:href="1678-4170-abc-100-04-0e51-30085-gt01.jpg"/></table-wrap>
    </p>
    <p>&#201; interessante notar que um VO<sub>2</sub>m&#225;x elevado ameniza o impacto negativo da presen&#231;a de outros conhecidos fatores de risco coronariano<sup>8</sup>. Em paralelo, outras pesquisas com quantifica&#231;&#227;o do padr&#227;o de atividade f&#237;sica regular, uma vari&#225;vel tamb&#233;m claramente associada ao VO<sub>2</sub>m&#225;x e a CFM, t&#234;m encontrado resultados similares e corroborando a impress&#227;o cl&#237;nica<sup>9</sup>. Nesse sentido, destaca-se um estudo recente envolvendo diversas coortes populacionais compreendendo um total de 650 mil indiv&#237;duos com idade entre 21 e 90 anos de idade, que encontrou uma rela&#231;&#227;o fortemente positiva entre realizar atividade f&#237;sica regular e expectativa de vida<sup>10</sup>. </p>
    <p>Posto que o VO<sub>2</sub>m&#225;x &#233; um valioso indicador de sa&#250;de e de desempenho f&#237;sico, vale a pena considerar o papel do exerc&#237;cio aer&#243;bico regular nas diferentes etapas da vida sobre essa vari&#225;vel. Dados recentes indicam que jogadores mais velhos (27 a 36 anos de idade) da elite do futebol profissional mant&#234;m valores de VO<sub>2</sub>m&#225;x similares aos mais jovens (17 a 22 anos de idade), sugerindo que &#233; poss&#237;vel permanecer com n&#237;veis bastante altos quando de treinamento apropriado<sup>11</sup>. Na realidade, esses dados apenas corroboram a observa&#231;&#227;o emp&#237;rica de que a maior parte dos resultados de excel&#234;ncia em maratonistas, triatletas e ciclistas de estrada de elite ocorre quando eles se encontram na 4&#170; ou 5&#170; d&#233;cada de vida. Nesse sentido, &#233; oportuno constatar que evid&#234;ncias recentes sinalizam para uma redu&#231;&#227;o da taxa de mortalidade quando o envelhecimento &#233; acompanhado por um estilo de vida mais ativo e uma queda proporcionalmente menor do VO<sub>2</sub>m&#225;x com a idade<sup>12</sup>. Pode-se supor que, com a crescente participa&#231;&#227;o de indiv&#237;duos de meia-idade e idosos em eventos desportivos de massa (por exemplo, meias-maratonas e maratonas), em um futuro pr&#243;ximo, dados cient&#237;ficos ir&#227;o identificar ainda mais precisamente os efeitos da desacelera&#231;&#227;o da redu&#231;&#227;o do VO<sub>2</sub>m&#225;x com a idade sobre a expectativa e a qualidade de vida relacionada &#224; sa&#250;de. </p>
    <p>Em s&#237;ntese, ter um VO<sub>2</sub>m&#225;x ou condi&#231;&#227;o aer&#243;bica reduzida, tanto em termos absolutos quanto relativo a idade e sexo, n&#227;o somente diminui a CFM e prejudica o desempenho f&#237;sico, como tamb&#233;m, o que &#233; mais importante, provoca um enorme impacto negativo sobre a taxa de mortalidade nos anos seguintes. Provavelmente nenhuma outra vari&#225;vel biol&#243;gica possui tanta relev&#226;ncia para a sa&#250;de quanto o VO<sub>2</sub>m&#225;x. Dessa forma, &#233; chegada a hora do cardiologista cl&#237;nico colocar a mensura&#231;&#227;o do VO<sub>2</sub>m&#225;x do seu paciente no topo das suas prioridades e decis&#245;es, sendo o TCPE o melhor instrumento proped&#234;utico para sua essa medida. </p>
    <p>
      <bold>Contribui&#231;&#227;o dos Autores</bold>
    </p>
    <p>Concep&#231;&#227;o e desenho da pesquisa, Obten&#231;&#227;o de dados, An&#225;lise e interpreta&#231;&#227;o dos dados, Reda&#231;&#227;o do manuscrito e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual: Ara&#250;jo CGS, Herdy AH, Stein R; Obten&#231;&#227;o de financiamento: Ara&#250;jo CGS.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Dr. Claudio Gil Soares de Ara&#250;jo - Potencial conflito: Aux&#237;lios de fabricantes e honor&#225;rios para palestras - Inbrasport e Micromed.</p>
    <p>Dr. Ricardo Stein - Potencial conflito: Aux&#237;lio de fabricante e honor&#225;rios para palestra - Inbrasport.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>Dr. Claudio Gil Soares de Ara&#250;jo recebe apoio financeiro do CNPq e da FAPERJ.</p>
    <p>Dr. Ricardo Stein recebe apoio financeiro do CNPq e da FAPERGS.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo com disserta&#231;&#245;es ou teses de programas de p&#243;s-gradua&#231;&#227;o.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Dr. Claudio Gil S. Ara&#250;jo </p>
        <p> CLINIMEX - Cl&#237;nica de Medicina do Exerc&#237;cio </p>
        <p> Rua Siqueira Campos, 93/101 </p>
        <p> 22031-070 - Rio de Janeiro, RJ - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="cgaraujo@iis.com.br">cgaraujo@iis.com.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 29/11/12; revisado em 09/01/13; aceito em 10/01/13.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Herdy AH, Uhlendorf D. Reference values for cardiopulmonary exercise testing for sedentary and active men and women. Arq Bras Cardiol. 2011;96(1):54-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Reference values for cardiopulmonary exercise testing for sedentary and active men and women</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2011</year>
          </date>
          <fpage>54</fpage>
          <lpage>9</lpage>
          <issue>1</issue>
          <volume>96</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Herdy</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Uhlendorf</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Hill AV, Lupton H. Muscular exercise, lactic acid, and the supply and utilization of oxygen. Quart J Med. 1923;16(1):135-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Muscular exercise, lactic acid, and the supply and utilization of oxygen</article-title>
          <source>Quart J Med</source>
          <date>
            <year>1923</year>
          </date>
          <fpage>135</fpage>
          <lpage>71</lpage>
          <issue>1</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hill</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Lupton</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Ara&#250;jo CG, Pinto VL. Freq&#252;&#234;ncia card&#237;aca m&#225;xima em testes de exerc&#237;cio em esteira rolante e em cicloerg&#244;metro de membros inferiores. Arq Bras Cardiol. 2005;85(1):45-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Freq&#252;&#234;ncia card&#237;aca m&#225;xima em testes de exerc&#237;cio em esteira rolante e em cicloerg&#244;metro de membros inferiores</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>45</fpage>
          <lpage>50</lpage>
          <issue>1</issue>
          <volume>85</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ara&#250;jo</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>VL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Kokkinos P, Myers J, Faselis C, Panagiotakos DB, Doumas M, Pittaras A, et al. Exercise capacity and mortality in older men: a 20-year follow-up study. Circulation. 2010;122(8):790-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise capacity and mortality in older men: a 20-year follow-up study</article-title>
          <source>Circulation</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>790</fpage>
          <lpage>7</lpage>
          <issue>8</issue>
          <volume>122</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kokkinos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Faselis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Panagiotakos</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Doumas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pittaras</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Laukkanen JA, Lakka TA, Rauramaa R, Kuhanen R, Venalainen JM, Salonen R, et al. Cardiovascular fitness as a predictor of mortality in men. Arch Intern Med. 2001;161(6):825-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiovascular fitness as a predictor of mortality in men</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>825</fpage>
          <lpage>31</lpage>
          <issue>6</issue>
          <volume>161</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Laukkanen</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Lakka</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Rauramaa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kuhanen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Venalainen</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Salonen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793-801.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise capacity and mortality among men referred for exercise testing</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>793</fpage>
          <lpage>801</lpage>
          <issue>11</issue>
          <volume>346</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Myers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Prakash</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Froelicher</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Do</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Partington</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Atwood</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Williams PT. Usefulness of cardiorespiratory fitness to predict coronary heart disease risk independent of physical activity. Am J Cardiol. 2010;106(2):210-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Usefulness of cardiorespiratory fitness to predict coronary heart disease risk independent of physical activity</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>210</fpage>
          <lpage>5</lpage>
          <issue>2</issue>
          <volume>106</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>PT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RS Jr, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999;282(16):1547-53.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men</article-title>
          <source>JAMA</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1547</fpage>
          <lpage>53</lpage>
          <issue>16</issue>
          <volume>282</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wei</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kampert</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Nichaman</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Gibbons</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Paffenbarger Jr</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Williams PT. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc. 2001;33(5):754-61.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Physical fitness and activity as separate heart disease risk factors: a meta-analysis</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>754</fpage>
          <lpage>61</lpage>
          <issue>5</issue>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>PT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Moore SC, Patel AV, Matthews CE, Berrington de Gonzalez A, Park Y, Katki HA, et al. Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med. 2012;9(11):e1001335.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis</article-title>
          <source>PLoS Med</source>
          <date>
            <year>2012</year>
          </date>
          <fpage>e1001335</fpage>
          <issue>11</issue>
          <volume>9</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Moore</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Berrington de Gonzalez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Katki</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Duarte CV, Ara&#250;jo CG. Cardiac vagal index does not explain age-independent maximal heart rate. Int J Sports Med. 2012 Nov 22. [Epub ahead of print]</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac vagal index does not explain age-independent maximal heart rate</article-title>
          <source>Int J Sports Med</source>
          <date>
            <year>2012</year>
            <day>22</day>
            <month>11</month>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Duarte</surname>
              <given-names>CV</given-names>
            </name>
            <name>
              <surname>Ara&#250;jo</surname>
              <given-names>CG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Petersen CB, Gronbaek M, Helge JW, Thygesen LC, Schnohr P, Tolstrup JS. Changes in physical activity in leisure time and the risk of myocardial infarction, ischemic heart disease, and all-cause mortality. Eur J Epidemiol. 2012;27(2):91-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Changes in physical activity in leisure time and the risk of myocardial infarction, ischemic heart disease, and all-cause mortality</article-title>
          <source>Eur J Epidemiol</source>
          <date>
            <year>2012</year>
          </date>
          <fpage>91</fpage>
          <lpage>9</lpage>
          <issue>2</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Petersen</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Gronbaek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Helge</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Thygesen</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Schnohr</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tolstrup</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cancer statistics, 2008</article-title>
          <source>CA Cancer J Clin</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>71</fpage>
          <lpage>96</lpage>
          <issue>2</issue>
          <volume>58</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jemal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Viewpoint</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Maximum oxygen consumption measurement: valuable biological marker in health and in sickness</article-title>
      </title-group>
    </front-stub>
    <body>
      <p>
        <bold>VIEWPOINT</bold>
      </p>
      <p>
        <fn id="enda-body2">
          <label>
            <bold>Maximum oxygen consumption measurement: valuable biological marker in health and in sickness</bold>
          </label>
          <p>
            <bold>Claudio Gil Soares de Ara&#250;jo<sup>I,II</sup>; Artur Haddad Herdy<sup>III,IV,V</sup>; Ricardo Stein<sup>VI,VII</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Programa de P&#243;s-Gradua&#231;&#227;o em Ci&#234;ncias do Exerc&#237;cio e do Esporte - Universidade Gama Filho</p>
      <p><sup>II</sup>Cl&#237;nica de Medicina do Exerc&#237;cio (Clinimex), Rio de Janeiro, RJ</p>
      <p><sup>III</sup>Instituto de Cardiologia de Santa Catarina</p>
      <p><sup>IV</sup>Cl&#237;nica Cardiosport</p>
      <p><sup>V</sup>Universidade do Sul de Santa Catarina (Unisul), Florian&#243;polis, SC</p>
      <p><sup>VI</sup>Departamento de Medicina Interna da Faculdade de Medicina - Universidade Federal do Rio Grande do Sul, Porto Alegre, RS</p>
      <p><sup>VII</sup>Vitta Exerc&#237;cio &amp; Cl&#237;nica de Sa&#250;de, Porto Alegre, RS - Brazil</p>
      <p>Mailing Address</p>
      <p><bold>Keywords:</bold> Cardiopulmonar exercise testing; Ergospirometry; Exercise testing; Aerobic fitness; Physical fitness; Functional evaluation.</p>
      <p>Human beings depend on atmospheric oxygen (O<sub>2</sub>) for survival. To perform physical work, it is necessary to increase the volume of air into the lungs, increase blood flow and activate specific metabolic in the skeletal muscles, resulting in an increased O<sub>2</sub> uptake and utilization. Integrated responses of the respiratory, cardiovascular and muscular systems in exercises involving large muscle groups increase up to a limit that defines the maximum oxygen consumption (VO<sub>2</sub>max) or aerobic fitness of the individual.</p>
      <p>Considering that the human body is a machine capable of transforming chemical energy into mechanical work, VO<sub>2</sub>max corresponds to physical performance, which is defined as Maximum Functional Capacity (MFC) and can be estimated with good accuracy. With the exception of extreme cases of greater or lower mechanical efficiency, such as athletes that are extremely technical regarding motor gestures or disabled individuals with greatly reduced functional capacity, there is usually a significant association between VO<sub>2</sub>max and MFC for virtually all other individuals<sup>1</sup>. This point of view briefly discusses the major historical and methodological aspects and the physiological, clinical and epidemiological significance of VO<sub>2</sub>max, as well as demonstrating its role as a marker of health status and physical performance.</p>
      <p>During exercise situations, the physiological mechanisms can increase alveolar ventilation 10 to 30 times; heart rate 3 to 4 times; cardiac output 5 to 6 times, and the arteriovenous peripheral extraction of O<sub>2</sub> at some times. Thus, VO<sub>2</sub> increases in direct proportion to the intensity of the effort. While VO<sub>2</sub>max tends to be higher in men and decrease with age, VO<sub>2</sub>max measurements eventually differ in humans. In resting conditions, an adult tends to consume slightly more than 200 mL of O<sub>2</sub> (approximately 1 kcal) per minute or something like 3.5 mL O<sub>2</sub>.kg<sup>-1</sup>. min<sup>-1</sup>. In order to simplify it, it was decided that this resting energy expenditure would be called 1 metabolic equivalent (MET).</p>
      <p>While some individuals with heart disease, lung disease and the elderly may be limited to only 3 or 4 METs or VO<sub>2</sub>max between 10 and 14 mL O<sub>2</sub>.kg<sup>-1</sup>.min<sup>-1</sup>, active middle-aged men tend to have a VO<sub>2</sub>max ranging between 25 and 35 mL O<sub>2</sub>. kg<sup>-1</sup>.min<sup>-1</sup>, adolescents and young adults between 35 and 55, and elite athletes in predominantly aerobic modalities may even exceed 70 mL O<sub>2</sub>.kg<sup>-1</sup>.min<sup>-1</sup><sup>2</sup>. Despite the fact that a young and healthy individual can reach VO<sub>2</sub>max in just over a minute during a sudden and very high-intensity effort, as it indeed occurs in several sports competitions, in the clinical practice exercise testing protocols are used with small increments or on a slow ramp, aiming to achieve a VO<sub>2</sub>max after approximately ten minutes and favoring the interpretation of different cardiorespiratory and ECG variables. </p>
      <p>Historically, it is known that the early studies of VO<sub>2</sub>max measurements were published more than a hundred years ago, which in fact contributed for physiologist Archibald V. Hill, one of the tested subjects and the author of these studies, to be awarded the Nobel Prize in Physiology and Medicine in 1922<sup>2</sup>. In Brazil, this measurement started to be performed primarily in exercise physiology labs in the early 70's. In a not so distant past, the assessment of VO<sub>2</sub>max was restricted to a few specialized centers. However, currently the number of sites able to effectively measure VO<sub>2</sub>max during a cardiopulmonary exercise test (CPET) has increased very rapidly. For instance, when considering all authors of this point of view, more than 20,000 procedures have been performed in the last 40 years. </p>
      <p>VO<sub>2</sub>max may be directly measured by analysis of expired gases during a CPET or estimated using equations based on distance traveled during a time period - for example, Cooper's test - or duration of an exercise test with a specific protocol (Bruce or Ellestad, for instance). Even if under some circumstances the use of these prediction equations may result in good association with the values obtained from direct measurements, the error for a given individual can be quite high, of around 15% to 20% and, in rare cases, up to or more than 30%, a margin of error that is not found in other measurements in the biological area. Thus, whenever possible and consistent with the current trend, it is preferable to perform a truly maximum CPET<sup>3</sup> and obtain more accurate and direct measures of VO<sub>2</sub>max.</p>
      <p>In situations where a limitation in VO<sub>2</sub>max is observed or when very low values are attained, much lower than those predicted for age and sex, a diagnostic meaning may ensue, especially when such results are to be compared with previous tests that showed normal results. However, the greatest relevance of determining the VO<sub>2</sub>max and MFC is in its prognostic use. Classic studies with large samples of middle-aged and elderly individuals from different parts of the world have repeatedly found that the risk of mortality from all causes in follow-ups between 5 and 20 years can vary from one to five times for individuals located in the most extreme quartiles or quintiles of VO<sub>2</sub>max or MFC<sup>4-6</sup>. For adult, middle-aged men, an increment of 3.5 mL O<sub>2</sub>.kg<sup>-1</sup>. min<sup>-1</sup> corresponds to a 12% gain in life expectancy<sup>6</sup>. Putting this information into the clinical perspective of individual risk stratification, one can compare the annual mortality rate of middle-aged men in different clinical conditions and VO<sub>2</sub>max (<xref ref-type="table" rid="en_a17ta01-body2">Table 1</xref>). Based on these epidemiological data, it is clear that having a proportionally high VO<sub>2</sub>max (or MFC) is a strong sign of health and longevity. Men that at the age of 50 complete a 10 km race in less than 50 minutes will show an excellent prognosis regarding life expectancy in the following 5 to 10 years<sup>7</sup>. On the other hand, "healthy" individuals (with normal cardiac assessment) and VO<sub>2</sub>max &lt; 17 mL O<sub>2</sub>.kg<sup>-1</sup>. min<sup>-1</sup> (approximately 50%-60% of predicted for age and gender) have an annual mortality rate of around 5%<sup>6</sup>, not very different from that observed after the diagnosis of colon cancer, which, according to the latest data from the U.S. CDC, is around 7%/year<sup>13</sup>.</p>
      <p content-type="asset">
        <table-wrap id="en_a17ta01-body2">
          <graphic xlink:href="1678-4170-abc-100-04-0e51-30085-gt01-en.jpg"/></table-wrap>
      </p>
      <p>It is interesting to note that a high VO<sub>2</sub>max attenuates the negative impact of the presence of other known coronary risk factors<sup>8</sup>. In parallel, other studies with quantification of regular physical activity pattern, a variable also clearly associated with VO<sub>2</sub>max and MFC, showed similar results, corroborating the clinical impression<sup>9</sup>. In this sense, there has been a recent study involving several population cohorts comprising a total of 650,000 individuals, aged 21 to 90 years old, which found a strong positive association between regular physical activity and life expectancy<sup>10</sup>.</p>
      <p>Considering that VO<sub>2</sub>max is a valuable indicator of health and physical performance, it is worth considering the effect of regular aerobic exercise at different stages of life upon this variable. Recent data indicate that VO<sub>2</sub>max values of older elite professional soccer players (27-36 years old) remain similar to those of younger ones (17-22 years old), suggesting that it is possible to maintain very high levels of VO<sub>2</sub>max when one has appropriate training<sup>11</sup>.</p>
      <p>In fact, these data only confirm the empirical observation that most of the excellent results observed in marathoners, triathletes and elite road cyclists occur when they are in their 4<sup>th</sup> or 5<sup>th</sup> decade of life. In this sense, it is noteworthy that recent evidence point to a reduction in mortality when aging is accompanied by a more active lifestyle and a proportionally smaller decrease in VO<sub>2</sub>max with age<sup>12</sup>. One can assume that with the increasing participation of middle-aged and elderly individuals in mass sporting events (e.g., half-marathons and marathons), in the near future, scientific data will identify with greater precision the effects of declining reduction of VO<sub>2</sub>max with age on survival and health-related quality of life.</p>
      <p>In short, having a reduced VO<sub>2</sub>max, or aerobic fitness, both in absolute terms and relative to age and sex, not only decreases the MFC and impairs physical performance, but also, what is more important, has an enormous negative impact on the mortality rate in subsequent years. Probably, no other biological variable has as much relevance to health as VO<sub>2</sub>max. Thus, it is about time for clinical cardiologists to have VO<sub>2</sub>max measurement of their patients at the top of their priorities and decisions, with CPET being the best propaedeutic tool for its measurement.</p>
      <p>
        <bold>Author contributions</bold>
      </p>
      <p>Conception and design of the research, Acquisition of data, Analysis and interpretation of the data, Writing of the manuscript and Critical revision of the manuscript for intellectual content: Ara&#250;jo CGS, Herdy AH, Stein R; Obtaining funding: Ara&#250;jo CGS.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>Dr. Claudio Gil Soares de Ara&#250;jo - Potential Conflict: Financial aid from manufacturers and lecture honoraria - Inbrasport e Micromed.</p>
      <p>Dr. Ricardo Stein - Potential Conflict: Financial aid from manufacturer and lecture honoraria - Inbrasport.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>Dr. Claudio Gil Soares de Ara&#250;jo is recipient of CNPq and FAPERJ research grants.</p>
      <p>Dr. Ricardo Stein is recipient of CNPq and FAPERGS research grants.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This study is not part of a dissertation or thesis</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
